Filtered By:
Procedure: Transplants
Therapy: Pain Management
This page shows you your search results in order of date.
Order by Relevance | Date
Total 671 results found since Jan 2013.
Pain management for liver transplant recipients
We present current evidence-based literature that reviews optimal pain management strategies for this challenging patient demographic.RECENT FINDINGS: Multiple studies have shown that thoracic epidurals provide superior pain control in open hepatic resections. Recent data suggests thoracic epidurals may be safely considered in select liver transplant recipients with normal preoperative coagulation status; however, this evidence is limited, and further studies are needed. When the risks of coagulopathy prohibit epidural placement, truncal blocks such as transversus abdominis plane blocks or quadratus lumborum blocks and abd...
Source: Current Opinion in Organ Transplantation - September 20, 2023 Category: Transplant Surgery Authors: Simrat Kaur Patrick Henthorn Adrian Hendrickse Source Type: research
Current and Emerging Applications of Fecal Microbiota Transplantation
Am J Nurs. 2023 Sep 7;Published Ahead of Print. doi: 10.1097/01.NAJ.0000978920.88346.77. Online ahead of print.ABSTRACTFecal microbiota transplantation (FMT) is a life-changing treatment for people with recurrent Clostridioides difficile infection (rCDI). Frequently acquired in the hospital, CDI can cause serious gastrointestinal symptoms, including persistent watery diarrhea, abdominal pain, and severe dehydration. Antibiotics, the primary treatment, can unfortunately disrupt the gut microbiome and lead to antimicrobial resistance. FMT involves introducing stool from a healthy donor into the affected recipient to strength...
Source: The American Journal of Nursing - September 7, 2023 Category: Nursing Authors: Kathy A Baker Carsyn Poole Source Type: research
Living liver donor pain management
Curr Opin Organ Transplant. 2023 Sep 8. doi: 10.1097/MOT.0000000000001099. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Optimal pain control in living liver donors undergoing hepatectomy is strongly recommended considering their unique status as healthy individuals willingly undergoing surgery for the benefit of the recipient. This review aims to examine and evaluate different strategies aimed at ensuring effective postoperative pain management in living liver donors.RECENT FINDINGS: Enhanced recovery after surgery (ERAS) protocols have proven effective in optimizing patient outcomes, including in living liver donor he...
Source: Current Opinion in Organ Transplantation - September 7, 2023 Category: Transplant Surgery Authors: Ryung A Kang Justin Sangwook Ko Source Type: research
Current and Emerging Applications of Fecal Microbiota Transplantation
Am J Nurs. 2023 Sep 7;Published Ahead of Print. doi: 10.1097/01.NAJ.0000978920.88346.77. Online ahead of print.ABSTRACTFecal microbiota transplantation (FMT) is a life-changing treatment for people with recurrent Clostridioides difficile infection (rCDI). Frequently acquired in the hospital, CDI can cause serious gastrointestinal symptoms, including persistent watery diarrhea, abdominal pain, and severe dehydration. Antibiotics, the primary treatment, can unfortunately disrupt the gut microbiome and lead to antimicrobial resistance. FMT involves introducing stool from a healthy donor into the affected recipient to strength...
Source: The American Journal of Nursing - September 7, 2023 Category: Nursing Authors: Kathy A Baker Carsyn Poole Source Type: research
Living liver donor pain management
Curr Opin Organ Transplant. 2023 Sep 8. doi: 10.1097/MOT.0000000000001099. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Optimal pain control in living liver donors undergoing hepatectomy is strongly recommended considering their unique status as healthy individuals willingly undergoing surgery for the benefit of the recipient. This review aims to examine and evaluate different strategies aimed at ensuring effective postoperative pain management in living liver donors.RECENT FINDINGS: Enhanced recovery after surgery (ERAS) protocols have proven effective in optimizing patient outcomes, including in living liver donor he...
Source: Current Opinion in Organ Transplantation - September 7, 2023 Category: Transplant Surgery Authors: Ryung A Kang Justin Sangwook Ko Source Type: research
Current and Emerging Applications of Fecal Microbiota Transplantation
Am J Nurs. 2023 Sep 7;Published Ahead of Print. doi: 10.1097/01.NAJ.0000978920.88346.77. Online ahead of print.ABSTRACTFecal microbiota transplantation (FMT) is a life-changing treatment for people with recurrent Clostridioides difficile infection (rCDI). Frequently acquired in the hospital, CDI can cause serious gastrointestinal symptoms, including persistent watery diarrhea, abdominal pain, and severe dehydration. Antibiotics, the primary treatment, can unfortunately disrupt the gut microbiome and lead to antimicrobial resistance. FMT involves introducing stool from a healthy donor into the affected recipient to strength...
Source: The American Journal of Nursing - September 7, 2023 Category: Nursing Authors: Kathy A Baker Carsyn Poole Source Type: research
Living liver donor pain management
Curr Opin Organ Transplant. 2023 Sep 8. doi: 10.1097/MOT.0000000000001099. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Optimal pain control in living liver donors undergoing hepatectomy is strongly recommended considering their unique status as healthy individuals willingly undergoing surgery for the benefit of the recipient. This review aims to examine and evaluate different strategies aimed at ensuring effective postoperative pain management in living liver donors.RECENT FINDINGS: Enhanced recovery after surgery (ERAS) protocols have proven effective in optimizing patient outcomes, including in living liver donor he...
Source: Current Opinion in Organ Transplantation - September 7, 2023 Category: Transplant Surgery Authors: Ryung A Kang Justin Sangwook Ko Source Type: research
Current and Emerging Applications of Fecal Microbiota Transplantation
Am J Nurs. 2023 Sep 7;Published Ahead of Print. doi: 10.1097/01.NAJ.0000978920.88346.77. Online ahead of print.ABSTRACTFecal microbiota transplantation (FMT) is a life-changing treatment for people with recurrent Clostridioides difficile infection (rCDI). Frequently acquired in the hospital, CDI can cause serious gastrointestinal symptoms, including persistent watery diarrhea, abdominal pain, and severe dehydration. Antibiotics, the primary treatment, can unfortunately disrupt the gut microbiome and lead to antimicrobial resistance. FMT involves introducing stool from a healthy donor into the affected recipient to strength...
Source: The American Journal of Nursing - September 7, 2023 Category: Nursing Authors: Kathy A Baker Carsyn Poole Source Type: research
